Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Clopidogrel × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

Cyclophosphamide 11 fludarabine phosphate 8 Peripheral Blood Stem Cell Transplantation 8 Azacitidine 8 fludarabine 7 Cytarabine 7 Busulfan 7 Whole-Body Irradiation 6 Methotrexate 5 Filgrastim 5 Cyclosporine 5 Tacrolimus 4 Mycophenolic Acid 4 nilotinib 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Decitabine 3 Dasatinib 3 venetoclax 2 sabatolimab 2 ruxolitinib 2 magrolimab 2 ivosidenib 2 decitabine and cedazuridine drug combination 2 Stem Cell Transplantation 2 Sirolimus 2 Saline Solution 2 Radiotherapy 2 Pentetic Acid 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00940784 2014-11-26

ISCLAP

Icahn School of Medicine at Mount Sinai

Phase 2 Withdrawn

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡